<DOC>
	<DOCNO>NCT02780791</DOCNO>
	<brief_summary>The purpose study determine whether pelvic wall ovary represent good location maturation follicle context ovarian transplantation cryopreservation ovarian tissue cytotoxic therapy .</brief_summary>
	<brief_title>Maturation Follicles After Transplantation Ovarian Tissue Into Pelvic Wall Ovary</brief_title>
	<detailed_description>The development modern medicine make likely oncological patient survive . Also , lot young female patient persistent wish kid . After aggressive chemotherapy , premature ovarian failure ( POF ) possible consequence therapy . Therefore , efficient fertility protective intervention request . The transplantation ovarian tissue cryopreservation valuable method , could remain fertility POF induce cytotoxic therapy . Especially girls suffer cancer , n't reach puberty yet , cryopreservation ovarian tissue opportunity preserve chance restore fertility POF . There two location , could use retransplantation cryopreserved tissue : remain ovary pelvic wall . Both , ovary subperitoneal pocket pelvic wall present location , maturation follicle possible . The remain question : follicle grow ? To answer question , study necessary . The purpose study determine whether pelvic wall ovary represent good location maturation follicle context ovarian transplantation cryopreservation ovarian tissue cytotoxic therapy . Interventions : Ovarian tissue transplant two different location ; subperitoneal loge adnexa uterus contralateral ovary . The assignment two part ovarian tissue place transplantation ( pelvic wall vs. ovary ) randomise . The study-specific intervention include : - Transplantation amount ovarian tissue location - Monthly sonographic control determination estradiol , LH , FSH progesterone 3rd 12th month transplantation . Therefore , blood sample make . - Monthly documentation duration cycle 3rd 12th month transplantation One year transplantation , investigator able determine location likely grow follicle . With gained knowledge , standardized recommendation could formulate help improve whole process medical care female oncologist patient .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<criteria>Age cryopreservation ot tissue max . 38 year Age transplantation 1849 year At least one maintain ovary Premature ovarian failure Indication autologous transplantation ovarian tissue Permitted pregnancy part oncologists Written informed consent Age transplantation &lt; 18 &gt; 49 year Cryopreservation context leucaemia , neuroblastoma , Burkittlymphoma Important : Inclusion do one recruiting center . Study participation give invitation . Please contact Principal Investigator !</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Infertility</keyword>
	<keyword>Ovarian Failure , Premature</keyword>
	<keyword>Ovarian Follicle</keyword>
	<keyword>Ovary</keyword>
	<keyword>Tissue Transplantation</keyword>
	<keyword>Cryopreservation</keyword>
	<keyword>Pelvis</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Pregnancy Rate</keyword>
	<keyword>Folliculogenesis</keyword>
	<keyword>Endometrium</keyword>
	<keyword>Estrogens</keyword>
	<keyword>Progestins</keyword>
	<keyword>Follicle Stimulating Hormone</keyword>
	<keyword>Estradiol</keyword>
	<keyword>Progesterone</keyword>
	<keyword>Hormones</keyword>
	<keyword>Maturation Follicles</keyword>
	<keyword>Pregnant Women</keyword>
	<keyword>Premature Menopause</keyword>
	<keyword>Ovarian Insufficiency</keyword>
	<keyword>Ovarian Insufficiency , Premature</keyword>
	<keyword>Cytotoxic therapy</keyword>
	<keyword>Fertility Protection</keyword>
	<keyword>Reproductive Medicine</keyword>
	<keyword>Reproductive Techniques</keyword>
	<keyword>Reproductive Technology</keyword>
	<keyword>Cryotherapy</keyword>
	<keyword>Pregnancy</keyword>
</DOC>